AAAbdulaziz Al-Quorain

Abdulaziz Al-Quorain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abdulaziz Al-Quorain has a total of 199 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bacterial and fungal biomarkers in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): trans-kingdom interactions, Blastocystis carriage, and enterotype–succinotype stratification

    by Ayman A. El-Badry, Abdulaziz A. Al-Quorain, Nehal Hosin, Mark van der Giezen, Yohannes Seyoum

    The gut microbiome, encompassing bacteria, fungi, and protists, is integral to gastrointestinal (GI) health and disease. While bacterial dysbiosis is well documented in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), fungal contributions and bacterial-fungal interactions remain underexplored, particularly in non-Western populations. We profiled bacterial (16S rRNA) and fungal (ITS) communities from stool samples of Saudi participants with IBS, ulcerative colitis (UC), Crohn’s disease (CD), and controls. Analyses incorporated bacterial enterotypes, succinotypes, and Blastocystis carriage to explore ecological and metabolic stratification. Differences in community composition were largely explained by GI disorder, host factors, enterotype, and Blastocystis carriage, accounting for 1–9% of bacterial and fungal variation. IBS patients exhibited increased bacterial richness and evenness, whereas UC and CD displayed stronger fungal dysbiosis. Enterotyping identified two Bacteroides -dominant clusters: Bact1 (with Faecalibacterium , Alistipes ) and Bact2 (enriched in Escherichia-Shigella , Streptococcus ), with Bact2 linked to reduced diversity and elevated calprotectin. Succinotyping distinguished Dialister -dominant (D-type) and Phascolarctobacterium -dominant (P-type) communities; UC was enriched in fragile, bridge-dependent D-type networks, in contrast to resilient, short-chain fatty acid (SCFA)- and H 2 S-producing P-type networks. Blastocystis was detected in 48% of participants (mainly subtypes 1 (ST1) and ST3). It was associated with enrichment of butyrate-producing bacteria ( Roseburia , Anaerobutyricum , Butyribacter ) and distinct fungal genera, with subtype-specific signatures (ST1 enriched in Alistipes , ST3 in Escherichia-Shigella ). Disease-associated biomarkers included UC-linked depletion of butyrate producers and enrichment of Cutibacterium , Comamonas , and Dialister ; depletion of Clostridia UCG-014 in CD; and enrichment of fermentative fungi ( Candida , Meyerozyma ) and bacteria ( Coprococcus , Catenibacterium ) in IBS. Cross-domain networks were resilient and modular in controls and IBS but fragile in UC and intermediate in CD. These findings highlight trans-kingdom interactions and Blastocystis carriage as ecological features of the gut microbiome in IBS and IBD, with enterotype-succinotype stratification offering complementary biomarkers for disease classification in a non-Western cohort.


  • Open Access

    Hepatobiliary manifestations of COVID-19 and their impact on severity and outcomes in a single center in Saudi Arabia

    by Reem Al Argan, Mona Ismail, Dania AlKhafaji, Raed Alsulaiman, Fatimah Ismaeel, Reem AlSulaiman, Lameyaa Alsheekh, Tariq Alsaif, Feras Alkuwaiti, Abir Al Said, et al.

    Recognizing hepatic manifestations of COVID-19 and their impact on the severity and outcome is crucial in managing this emerging pandemic. However, we lack such reported data in Saudi Arabia regarding this clinical entity. This is a retrospective observational study conducted on 387 patients with COVID-19 disease who were hospitalized at King Fahad Hospital of the University from March-September 2020. The total cohort was divided into two groups: liver and non-liver involvement. Then, the frequency of hepatic manifestations was determined, followed by comparing severity and outcome among the two study groups. A total of 387 patients were included, of which 72.87% had hepatic manifestations. The most prevalent abnormalities were high LDH in 308 (79.58%) followed by AST 205 (52.97%), GGTP 124 (31.26%), ALT 74 (19.12%), PT/INR 66 (17.05%), direct bilirubin 51 (12.40%), total bilirubin 46 (11.88%), and low albumin 48 (12.4%). Univariate analyses showed that liver involvement was significantly associated with severe (31.91%) and critical (34.75%) presentation (P<0.001). Multivariate regression analysis showed that the presence of liver involvement was an independent risk factor for severe or critical COVID-19 disease (OR 2.44; P<0.001), longer hospitalization (OR 2.27; P=0.001), and ICU admission (OR 2.27; P=0.006). The current study showed that liver involvement is common in the setting of COVID-19 disease. Such patients had a higher disease severity and a worse clinical outcome.


  • Magnetic resonance and retrograde endoscopic cholangiopancreatography-based identification of biliary tree variants: are there type-related variabilities among the Saudi population?

    by Abdelhamied Mohamed Lutfi, Abdulrahman Hamad Al-Abdulwahhab, Abdulaziz Mohammad Al-Sharydah, Abdulaziz Al-Quorain, Afnan Fahd Al-Muhanna, Bander Fuhaid Al-Dhaferi

    This study investigated biliary tree patterns in a Saudi Arabian population to identify common anatomical variations to establish a common ground for improved surgical practice and to avoid unexpected complications. We consider this type of investigation clinically important because the findings are valuable for pre-surgical planning in a broad range of procedures, including laparoscopic cholecystectomy and liver transplantation.


  • Open Access

    Mind the Gap: Successful Endoscopic Closure of a Large Gastric Sleeve Leak Using an Endoscopic Stent and Over-the-Scope Clips

    by Jiannis Anastasiou, Anas Hussameddin, Abdulaziz Al Quorain

    Laparoscopic sleeve gastrectomy (LSG) is gaining popularity for the treatment of morbid obesity. It is regarded as a simple, low-cost procedure achieving significant weight loss within a short period of time. LSG is considered a safe procedure with a relatively low complication rate. The complications encountered nevertheless can result in significant morbidity and may even be lethal. The most significant complications are staple-line bleeding, stricture, and staple-line leak. The purpose of this paper is to present a case of a 31-year-old patient complicated by a 3.06 cm staple-line leak 10 days after LSG. Review of the current literature regarding this complication as well as outline of a strategy for the management of large post-LSG gastric leaks is suggested.


  • Open Access

    Novel KRAS Gene Mutations in Sporadic Colorectal Cancer

    by Walid M. Naser, Mohamed A. Shawarby, Dalal M. Al-Tamimi, Arun Seth, Abdulaziz Al-Quorain, Areej M. Al Nemer, Omar M. E. Albagha

    In this article, we report 7 novel KRAS gene mutations discovered while retrospectively studying the prevalence and pattern of KRAS mutations in cancerous tissue obtained from 56 Saudi sporadic colorectal cancer patients from the Eastern Province. Genomic DNA was extracted from formalin-fixed, paraffin-embedded cancerous and noncancerous colorectal tissues. Successful and specific PCR products were then bi-directionally sequenced to detect exon 4 mutations while Mutector II Detection Kits were used for identifying mutations in codons 12, 13 and 61. The functional impact of the novel mutations was assessed using bioinformatics tools and molecular modeling. KRAS gene mutations were detected in the cancer tissue of 24 cases (42.85%). Of these, 11 had exon 4 mutations (19.64%). They harbored 8 different mutations all of which except two altered the KRAS protein amino acid sequence and all except one were novel as revealed by COSMIC database. The detected novel mutations were found to be somatic. One mutation is predicted to be benign. The remaining mutations are predicted to cause substantial changes in the protein structure. Of these, the Q150X nonsense mutation is the second truncating mutation to be reported in colorectal cancer in the literature. Our discovery of novel exon 4 KRAS mutations that are, so far, unique to Saudi colorectal cancer patients may be attributed to environmental factors and/or racial/ethnic variations due to genetic differences. Alternatively, it may be related to paucity of clinical studies on mutations other than those in codons 12, 13, 61 and 146. Further KRAS testing on a large number of patients of various ethnicities, particularly beyond the most common hotspot alleles in exons 2 and 3 is needed to assess the prevalence and explore the exact prognostic and predictive significance of the discovered novel mutations as well as their possible role in colorectal carcinogenesis.


  • Incidence of Pediatric Inflammatory Bowel Disease in Saudi Arabia

    by Mohammad I. El Mouzan, Omar Saadah, Khalid Al-Saleem, Mohammad Al Edreesi, Mohammed Hasosah, Aziz Alanazi, Mohammad Al Mofarreh, Ali Asery, Abdulaziz Al Qourain, Khaled Nouli, et al.

    Pediatric inflammatory bowel disease (IBD) is increasingly recognized in developing countries; however, the incidence and trend over time have not been reported. This retrospective study included children diagnosed with IBD in gastroenterology centers in the Kingdom of Saudi Arabia between 2003 and 2012. The date of birth, date and age at diagnosis, gender, and final diagnosis were collected on special forms. Clinical, laboratory, imaging, endoscopy, and histopathology results were reviewed to confirm the final diagnosis. Descriptive statistics were used to compare ulcerative colitis and Crohn's disease in different age groups, and significance was assessed by the chi-square test. Incidence rates and trend over time were analyzed with the assumption of Poisson distribution. The incidence rate over time was compared in 2 periods (2003-2007 and 2008-2012). A P value of <0.05 and 95% confidence intervals were used to assess the significance and precision of the estimates. A total of 340 Saudi Arabian children aged 0 to 14 years were diagnosed. The mean incidence rate per 100,000 individuals was 0.2, 0.27, and 0.47 for ulcerative colitis, Crohn's disease, and IBD, respectively. Except for the 0- to 4-year age group, there was a significant increase in incidence over time. Although the incidence of pediatric IBD in Saudi Arabian children is lower than suggested in the Western literature, there is a significantly increasing trend over time. However, decreased trend in the younger age group over time is identified. Prospective studies will be important to identify the risk factors for IBD in different age groups.


  • Open Access

    Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease

    by Mona H Ismail, Abdulmohsen H Al-Elq, MahdiE Al-Jarodi, NahlaA Azzam, Abdulrahman M Aljebreen, SamiA Al-Momen, Bahaa F Bseiso, FatmaA Al-Mulhim, Abdulaziz Alquorain

    Background/Aims: Metabolic bone disease is common in patients with inflammatory bowel disease (IBD). Our aim was to determine the frequency of bone loss among Saudi patients with IBD and possible contributing risk factors. Settings and Design: We retrospectively reviewed Saudi patients with IBD, between 18 and 70 years of age, who had bone mass density (BMD) determined by dual-energy X-ray absorptiometry scanning at one of three hospitals in the Kingdom of Saudi Arabia from 2001 to 2008. Patients and Methods: Case notes and BMDs results were carefully reviewed for demographic and clinical data. Low bone mass, osteopenia, and osteoporosis were defined according to the WHO guidelines. Statistical Analysis Used: Predictive factors for BMD were analyzed using group comparisons and stepwise regression analyses. Results: Ninety-five patients were included; 46% had Crohn's disease (CD) and 54% had ulcerative colitis (UC). The average age was 30.9±11.6 years. Using T-scores, the frequency of osteopenia was 44.2%, and the frequency of osteoporosis was 30.5% at both lumbar spine and proximal femur. Only 25.3% of patients exhibited a BMD within the normal range. Our results revealed a positive correlation between the Z-score in both the lumbar spine and the proximal femur and body mass index (BMI) (P=0.042 and P=0.018, respectively). On regression analysis BMI, age, and calcium supplementation were found to be the most important independent predictors of BMD. Conclusions: Saudi patients with IBD are at an increased risk of low BMD and the frequency of decreased BMD in Saudi patients with CD and UC were similar. BMI and age were the most important independent predictors of low BMD.


  • Open Access

    Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia

    by Talay Yar, Eyad M Salem, AbdullahO Bamosa, Abdulaziz Al-Quorain, MohamedI Yasawy, Raed M Alsulaiman, MuhammadA Randhawa

    Background/Aim: A large number of diseases are ascribed to Helicobacter pylori (H. pylori), particularly chronic active gastritis, peptic ulcer disease and gastric cancer. Successful treatment of H. pylori infection with antimicrobial agents can lead to regression of H. pylori-associated disorders. Antibiotic resistance against H. pylori is increasing, and it is necessary to find new effective agents. Nigella sativa seed (NS), a commonly used herb, possesses in vitro anti-helicobacter activity. The present study was undertaken to evaluate the efficacy of NS in eradication of H. pylori infection in non-ulcer dyspeptic patients. Materials and Methods: The study was conducted on 88 adult patients attending King Fahd Hospital of the University, Al-Khobar, Saudi Arabia, from 2007 to 2008, with dyspeptic symptoms and found positive for H. pylori infection by histopathology and urease test. Patients were randomly assigned to four groups, receiving i) triple therapy (TT) comprising of clarithromycin, amoxicillin, omeprazole [n= 23], ii) 1 g NS + 40 mg omeprazole (OM) [n= 21], iii) 2 g NS + OM [n= 21] or iv) 3 g NS + OM [n= 23]. Negative H. pylori stool antigen test four weeks after end of treatment was considered as eradication. Results: H. pylori eradication was 82.6, 47.6, 66.7 and 47.8% with TT, 1 g NS, 2 g NS and 3 g NS, respectively. Eradication rates with 2 g NS and TT were statistically not different from each other, whereas H. pylori eradication with other doses was significantly less than that with TT (P < 0.05). Dyspepsia symptoms improved in all groups to a similar extent. Conclusions: N. sativa seeds possess clinically useful anti-H. pylori activity, comparable to triple therapy. Further clinical studies combining N. sativa with antibiotics are suggested.


  • Open Access

    Prevalence of gastroesophageal reflux disease and its association with Helicobacter pylori infection in chronic renal failure patients and in renal transplant recipients

    by Ibrahiem S Abdulrahman, AbdulazizA Al-Quorain

    Background/Aims: The prevalence of gastroesophageal reflux disease (GERD) in chronic renal failure patients and in renal transplant recipients (RTR) has been a subject of discussion in the last few years. Our aims are to clarify this association and its relation to Helicobacter pylori infection, and also to identify possible pathogenic factors in the development of this disease in both groups. Methods: The study involved 40 end-stage renal disease (ESRD) patients with upper gastrointestinal (GI) symptoms (group I), 36 patients who had undergone kidney transplantation and had similar symptoms (group II), and 44 age- and sex-matched controls with the same upper GI symptoms (group III). All patients were subjected to esophagogastroduodenoscopy, and biopsies were obtained from the antrum for histological evaluation and identification of H. pylori . Results: The prevalence of GERD in the first two groups was similar (77.5 vs. 75.0%, P = 0.412), while it was significantly lower in the control group (38.6%, P < 0.01). H. pylori infection was present in 40.0, 36.1 ( P > 0.05) and 75% ( P < 0.01 and < 0.001) of the patients in groups I, II, and III, respectively . Multivariate logistic regression analysis in groups I and II showed that high serum creatinine (Odds ratio [OR] = 6.78, 95% Confidence Interval (CI) = 1.12-45.82), immunosuppressive therapy (OR = 5.78, 95% CI = 1.01-32.5), and absence of H. pylori infection (OR = 3.58, 94% CI = 1.11-18.6) were significantly associated with GERD. The duration of ESRD correlated significantly with the prevalence of GERD in group I. Conclusions: This study showed a similar prevalence of H. pylori infection and GERD in ESRD and RTR patients. GERD prevalence was higher in these two groups than in the controls. Renal transplantation, chronic renal disease, immunosuppressive therapy, and the absence of H. pylori infection seem to be risk factors for the development of GERD.


  • Open Access

    Handlebar hernia: A rare type of abdominal wall hernia

    by Khairi A.F Hassan, MohamedA Elsharawy, Khaled Moghazy, Abdulaziz AlQurain

    Handlebar hernias are abdominal wall hernias resulting from direct trauma to the anterior abdominal wall. They usually result at weak anatomic locations of the abdominal wall. Such traumatic hernias are rare, requiring a high index of suspicion for a clinical diagnosis. We report the case of a handlebar hernia resulting from an injury sustained during a vehicular injury, and discuss the management of such injuries.